

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 6.43539533 |
| 2 | ethanol oxidation (GO:0006069) | 6.22088764 |
| 3 | drug catabolic process (GO:0042737) | 5.81910860 |
| 4 | ethanol metabolic process (GO:0006067) | 5.55591616 |
| 5 | regulation of protein activation cascade (GO:2000257) | 5.41635341 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 5.30347326 |
| 7 | regulation of complement activation (GO:0030449) | 5.26773843 |
| 8 | complement activation, alternative pathway (GO:0006957) | 5.23760435 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 5.06016058 |
| 10 | regulation of fibrinolysis (GO:0051917) | 4.84860744 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.62848681 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 4.62848681 |
| 13 | omega-hydroxylase P450 pathway (GO:0097267) | 4.56672245 |
| 14 | primary alcohol catabolic process (GO:0034310) | 4.31475189 |
| 15 | glyoxylate metabolic process (GO:0046487) | 4.26279412 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.21592711 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 4.21592711 |
| 18 | protein carboxylation (GO:0018214) | 4.12372538 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.12372538 |
| 20 | negative regulation of cholesterol transport (GO:0032375) | 4.06306982 |
| 21 | negative regulation of sterol transport (GO:0032372) | 4.06306982 |
| 22 | drug metabolic process (GO:0017144) | 4.06154580 |
| 23 | amino-acid betaine metabolic process (GO:0006577) | 4.05577760 |
| 24 | cellular glucuronidation (GO:0052695) | 4.05552961 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.01539646 |
| 26 | urea metabolic process (GO:0019627) | 3.97117894 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 3.86771428 |
| 28 | glucuronate metabolic process (GO:0019585) | 3.81639153 |
| 29 | uronic acid metabolic process (GO:0006063) | 3.81639153 |
| 30 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77937132 |
| 31 | fibrinolysis (GO:0042730) | 3.75640385 |
| 32 | negative regulation of protein activation cascade (GO:2000258) | 3.75231536 |
| 33 | protein activation cascade (GO:0072376) | 3.73932886 |
| 34 | complement activation, classical pathway (GO:0006958) | 3.73473846 |
| 35 | phospholipid efflux (GO:0033700) | 3.72627557 |
| 36 | bile acid biosynthetic process (GO:0006699) | 3.71443127 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 3.71290839 |
| 38 | bile acid metabolic process (GO:0008206) | 3.70293806 |
| 39 | complement activation (GO:0006956) | 3.69220808 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 3.57371630 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 3.56453068 |
| 42 | macromolecular complex remodeling (GO:0034367) | 3.56453068 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 3.56453068 |
| 44 | negative regulation of humoral immune response (GO:0002921) | 3.53742349 |
| 45 | regulation of humoral immune response (GO:0002920) | 3.49063976 |
| 46 | alpha-linolenic acid metabolic process (GO:0036109) | 3.47893842 |
| 47 | axonemal dynein complex assembly (GO:0070286) | 3.47096935 |
| 48 | regulation of apoptotic cell clearance (GO:2000425) | 3.44589370 |
| 49 | response to mercury ion (GO:0046689) | 3.44253947 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 3.41852637 |
| 51 | negative regulation of complement activation (GO:0045916) | 3.40156549 |
| 52 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.39643070 |
| 53 | acylglycerol homeostasis (GO:0055090) | 3.39247236 |
| 54 | triglyceride homeostasis (GO:0070328) | 3.39247236 |
| 55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.38454345 |
| 56 | urea cycle (GO:0000050) | 3.37658349 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 3.37655251 |
| 58 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.37203194 |
| 59 | aromatic amino acid family catabolic process (GO:0009074) | 3.37007472 |
| 60 | reverse cholesterol transport (GO:0043691) | 3.33818539 |
| 61 | bile acid and bile salt transport (GO:0015721) | 3.32654225 |
| 62 | carnitine metabolic process (GO:0009437) | 3.30699198 |
| 63 | primary alcohol metabolic process (GO:0034308) | 3.30661867 |
| 64 | cholesterol efflux (GO:0033344) | 3.28591231 |
| 65 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.26319602 |
| 66 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.26319602 |
| 67 | negative regulation of blood coagulation (GO:0030195) | 3.26152382 |
| 68 | negative regulation of hemostasis (GO:1900047) | 3.26152382 |
| 69 | flavonoid metabolic process (GO:0009812) | 3.14617324 |
| 70 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.13105211 |
| 71 | acute-phase response (GO:0006953) | 3.08364929 |
| 72 | positive regulation of hemostasis (GO:1900048) | 3.07282494 |
| 73 | positive regulation of blood coagulation (GO:0030194) | 3.07282494 |
| 74 | negative regulation of lipase activity (GO:0060192) | 3.06428571 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 3.04363090 |
| 76 | phospholipid homeostasis (GO:0055091) | 3.00839536 |
| 77 | oxidative demethylation (GO:0070989) | 2.98209592 |
| 78 | phenylpropanoid metabolic process (GO:0009698) | 2.94982196 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 2.91672264 |
| 80 | negative regulation of coagulation (GO:0050819) | 2.91666697 |
| 81 | plasma lipoprotein particle organization (GO:0071827) | 2.91444145 |
| 82 | positive regulation of coagulation (GO:0050820) | 2.91433980 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 2.84249792 |
| 84 | regulation of plasminogen activation (GO:0010755) | 2.83781786 |
| 85 | xenobiotic metabolic process (GO:0006805) | 2.83382380 |
| 86 | glutamate metabolic process (GO:0006536) | 2.81474561 |
| 87 | protein-lipid complex subunit organization (GO:0071825) | 2.79420836 |
| 88 | intestinal cholesterol absorption (GO:0030299) | 2.77258086 |
| 89 | regulation of cholesterol metabolic process (GO:0090181) | 2.76828579 |
| 90 | sodium ion homeostasis (GO:0055078) | 2.76133068 |
| 91 | triglyceride catabolic process (GO:0019433) | 2.74877990 |
| 92 | serine family amino acid catabolic process (GO:0009071) | 2.73634348 |
| 93 | negative regulation of wound healing (GO:0061045) | 2.73482721 |
| 94 | hormone catabolic process (GO:0042447) | 2.73205713 |
| 95 | alkaloid metabolic process (GO:0009820) | 2.72736408 |
| 96 | neutral lipid catabolic process (GO:0046461) | 2.70412391 |
| 97 | acylglycerol catabolic process (GO:0046464) | 2.70412391 |
| 98 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.69353548 |
| 99 | negative regulation of B cell mediated immunity (GO:0002713) | 2.69353548 |
| 100 | low-density lipoprotein particle clearance (GO:0034383) | 2.65247087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.32379017 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.77584186 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.47770422 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.29687673 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.18043178 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.06444752 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.01557458 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.41785686 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.23453694 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97132506 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.94949028 |
| 12 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.83569102 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75826097 |
| 14 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.73021528 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71914529 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65619128 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63036477 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57927416 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51311600 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46480835 |
| 21 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.43522844 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39292880 |
| 23 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37717106 |
| 24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.36847558 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32789909 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32002499 |
| 27 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.31410332 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26841730 |
| 29 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25686728 |
| 30 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.25233282 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24720130 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23990083 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23544507 |
| 34 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19854068 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17996958 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.17615103 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14604424 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11772374 |
| 39 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11099874 |
| 40 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08820523 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07086620 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06694592 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03631246 |
| 44 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02979924 |
| 45 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02606828 |
| 46 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02494671 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01969514 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00258622 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98348930 |
| 50 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94138748 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93930152 |
| 52 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93147145 |
| 53 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93147145 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.93011908 |
| 55 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92910555 |
| 56 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91231343 |
| 57 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89399037 |
| 58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89365595 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88173505 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87650509 |
| 61 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.86919397 |
| 62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83989623 |
| 63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83364402 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83228220 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82412458 |
| 66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82310479 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.81984177 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 0.81859940 |
| 69 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81770282 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81336073 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80984103 |
| 72 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80895159 |
| 73 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.80419003 |
| 74 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.79450443 |
| 75 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77838363 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77545311 |
| 77 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76898879 |
| 78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.76886929 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76310283 |
| 80 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.76248520 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75651123 |
| 82 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.74529350 |
| 83 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.73195529 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72190958 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72068793 |
| 86 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.70186917 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70012508 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.69418666 |
| 89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.68348202 |
| 90 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.67793128 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67453872 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67453872 |
| 93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.67243565 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.67198785 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.66638516 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.66079043 |
| 97 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.65748660 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64500686 |
| 99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64292645 |
| 100 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.63843562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.04885399 |
| 2 | MP0005365_abnormal_bile_salt | 4.69749844 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 4.48772901 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.18938370 |
| 5 | MP0005360_urolithiasis | 3.87989343 |
| 6 | MP0003195_calcinosis | 3.36344697 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.00981588 |
| 8 | MP0003252_abnormal_bile_duct | 2.69078766 |
| 9 | MP0003868_abnormal_feces_composition | 2.48556885 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.47244086 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.44182130 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.42961447 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.38204182 |
| 14 | MP0003690_abnormal_glial_cell | 2.27263425 |
| 15 | MP0005670_abnormal_white_adipose | 2.24676256 |
| 16 | MP0009840_abnormal_foam_cell | 2.06781479 |
| 17 | MP0004043_abnormal_pH_regulation | 2.04855815 |
| 18 | MP0004130_abnormal_muscle_cell | 2.04278976 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.94734418 |
| 20 | MP0005332_abnormal_amino_acid | 1.93839622 |
| 21 | MP0002971_abnormal_brown_adipose | 1.73773134 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.69304564 |
| 23 | MP0002132_abnormal_respiratory_system | 1.66181157 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.62120378 |
| 25 | MP0000609_abnormal_liver_physiology | 1.60318486 |
| 26 | MP0003879_abnormal_hair_cell | 1.52616366 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.48534965 |
| 28 | MP0000604_amyloidosis | 1.46529059 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.45876314 |
| 30 | MP0003724_increased_susceptibility_to | 1.41364076 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.37642728 |
| 32 | MP0003329_amyloid_beta_deposits | 1.35136697 |
| 33 | MP0003303_peritoneal_inflammation | 1.33875504 |
| 34 | MP0003075_altered_response_to | 1.29118703 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.28436430 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.26335941 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24601636 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.19543786 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 1.19045506 |
| 40 | MP0005535_abnormal_body_temperature | 1.16726480 |
| 41 | MP0001661_extended_life_span | 1.11712775 |
| 42 | MP0001764_abnormal_homeostasis | 1.09535104 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.01773391 |
| 44 | MP0004883_abnormal_blood_vessel | 1.01735052 |
| 45 | MP0009115_abnormal_fat_cell | 0.99520638 |
| 46 | MP0002909_abnormal_adrenal_gland | 0.98826128 |
| 47 | MP0003011_delayed_dark_adaptation | 0.98334159 |
| 48 | MP0000920_abnormal_myelination | 0.97183138 |
| 49 | MP0001756_abnormal_urination | 0.94951960 |
| 50 | MP0005464_abnormal_platelet_physiology | 0.94323605 |
| 51 | MP0002638_abnormal_pupillary_reflex | 0.93616840 |
| 52 | MP0005451_abnormal_body_composition | 0.93418861 |
| 53 | MP0003172_abnormal_lysosome_physiology | 0.92908462 |
| 54 | MP0005334_abnormal_fat_pad | 0.92024799 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.91797619 |
| 56 | MP0005166_decreased_susceptibility_to | 0.91410127 |
| 57 | MP0005083_abnormal_biliary_tract | 0.89790557 |
| 58 | MP0005164_abnormal_response_to | 0.88880038 |
| 59 | MP0009642_abnormal_blood_homeostasis | 0.87383729 |
| 60 | MP0000681_abnormal_thyroid_gland | 0.87163752 |
| 61 | MP0001765_abnormal_ion_homeostasis | 0.86312990 |
| 62 | MP0000249_abnormal_blood_vessel | 0.86128637 |
| 63 | MP0008469_abnormal_protein_level | 0.85796954 |
| 64 | MP0002168_other_aberrant_phenotype | 0.83982665 |
| 65 | MP0003633_abnormal_nervous_system | 0.83807643 |
| 66 | MP0003638_abnormal_response/metabolism_ | 0.83013974 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 0.81112467 |
| 68 | MP0003300_gastrointestinal_ulcer | 0.80832578 |
| 69 | MP0001984_abnormal_olfaction | 0.80503880 |
| 70 | MP0009763_increased_sensitivity_to | 0.80231699 |
| 71 | MP0001501_abnormal_sleep_pattern | 0.79821531 |
| 72 | MP0005448_abnormal_energy_balance | 0.78146724 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.77764803 |
| 74 | MP0005387_immune_system_phenotype | 0.77391576 |
| 75 | MP0001790_abnormal_immune_system | 0.77391576 |
| 76 | MP0005025_abnormal_response_to | 0.74653779 |
| 77 | MP0002419_abnormal_innate_immunity | 0.74439193 |
| 78 | MP0010155_abnormal_intestine_physiology | 0.73981632 |
| 79 | MP0009764_decreased_sensitivity_to | 0.73369483 |
| 80 | MP0000685_abnormal_immune_system | 0.73274374 |
| 81 | MP0003632_abnormal_nervous_system | 0.73157700 |
| 82 | MP0005375_adipose_tissue_phenotype | 0.71715745 |
| 83 | MP0004147_increased_porphyrin_level | 0.71446202 |
| 84 | MP0003436_decreased_susceptibility_to | 0.70307215 |
| 85 | MP0010368_abnormal_lymphatic_system | 0.69306864 |
| 86 | MP0005376_homeostasis/metabolism_phenot | 0.68779821 |
| 87 | MP0006082_CNS_inflammation | 0.67721641 |
| 88 | MP0003631_nervous_system_phenotype | 0.67225336 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.66985331 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.66809352 |
| 91 | MP0000598_abnormal_liver_morphology | 0.66497326 |
| 92 | MP0004885_abnormal_endolymph | 0.65963102 |
| 93 | MP0008874_decreased_physiological_sensi | 0.64510177 |
| 94 | MP0001533_abnormal_skeleton_physiology | 0.64431729 |
| 95 | MP0001851_eye_inflammation | 0.63276990 |
| 96 | MP0005647_abnormal_sex_gland | 0.62652858 |
| 97 | MP0003953_abnormal_hormone_level | 0.61730765 |
| 98 | MP0009785_altered_susceptibility_to | 0.59938072 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.57626229 |
| 100 | MP0002970_abnormal_white_adipose | 0.56189338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 7.12899886 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.54438830 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.97708956 |
| 4 | Abnormality of complement system (HP:0005339) | 5.68214057 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.67168765 |
| 6 | Glomerulonephritis (HP:0000099) | 4.79870261 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.68634602 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.52402384 |
| 9 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.35806987 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.35777420 |
| 11 | Xanthomatosis (HP:0000991) | 3.98711573 |
| 12 | Absent/shortened dynein arms (HP:0200106) | 3.98202030 |
| 13 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.98202030 |
| 14 | Joint hemorrhage (HP:0005261) | 3.97221196 |
| 15 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.95924789 |
| 16 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.95924789 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.94215430 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.88584176 |
| 19 | Abnormal ciliary motility (HP:0012262) | 3.80524837 |
| 20 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.77157763 |
| 21 | Rhinitis (HP:0012384) | 3.57196075 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 3.48106507 |
| 23 | Nephritis (HP:0000123) | 3.38580838 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 2.98588329 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98173358 |
| 26 | Hyperactive renin-angiotensin system (HP:0000841) | 2.97798278 |
| 27 | Hemorrhage of the eye (HP:0011885) | 2.93564032 |
| 28 | Fat malabsorption (HP:0002630) | 2.92169428 |
| 29 | Chronic bronchitis (HP:0004469) | 2.91829957 |
| 30 | Intrahepatic cholestasis (HP:0001406) | 2.85171333 |
| 31 | Nasal polyposis (HP:0100582) | 2.76199739 |
| 32 | Bronchiectasis (HP:0002110) | 2.75551578 |
| 33 | Spontaneous abortion (HP:0005268) | 2.73963889 |
| 34 | Purpura (HP:0000979) | 2.71009333 |
| 35 | Hypolipoproteinemia (HP:0010981) | 2.68778764 |
| 36 | Decreased circulating renin level (HP:0003351) | 2.63650316 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.63166183 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 2.57320584 |
| 39 | Steatorrhea (HP:0002570) | 2.47032153 |
| 40 | Gingival bleeding (HP:0000225) | 2.43625863 |
| 41 | Rickets (HP:0002748) | 2.43412716 |
| 42 | Mitral stenosis (HP:0001718) | 2.40351306 |
| 43 | Hypercholesterolemia (HP:0003124) | 2.37566063 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.34539201 |
| 45 | Vascular calcification (HP:0004934) | 2.33122855 |
| 46 | Epidermoid cyst (HP:0200040) | 2.32117787 |
| 47 | Amyloidosis (HP:0011034) | 2.32025830 |
| 48 | Hyperammonemia (HP:0001987) | 2.31541400 |
| 49 | Pulmonary embolism (HP:0002204) | 2.28791372 |
| 50 | Alkalosis (HP:0001948) | 2.26054851 |
| 51 | Abnormality of renin-angiotensin system (HP:0000847) | 2.24033741 |
| 52 | Hyperaldosteronism (HP:0000859) | 2.20569100 |
| 53 | Bronchitis (HP:0012387) | 2.14816157 |
| 54 | Hypokalemic alkalosis (HP:0001949) | 2.13294686 |
| 55 | Poikilocytosis (HP:0004447) | 2.06662065 |
| 56 | Hyperglycinuria (HP:0003108) | 2.05196202 |
| 57 | Thrombophlebitis (HP:0004418) | 2.03852471 |
| 58 | Hydroxyprolinuria (HP:0003080) | 2.01302270 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.01302270 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.00267601 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96546246 |
| 62 | Mucopolysacchariduria (HP:0008155) | 1.96546246 |
| 63 | Facial shape deformation (HP:0011334) | 1.95207038 |
| 64 | Potter facies (HP:0002009) | 1.95207038 |
| 65 | Recurrent otitis media (HP:0000403) | 1.94869487 |
| 66 | Polycythemia (HP:0001901) | 1.93676170 |
| 67 | Skin nodule (HP:0200036) | 1.88546022 |
| 68 | Abnormality of glycine metabolism (HP:0010895) | 1.86413152 |
| 69 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86413152 |
| 70 | Renal salt wasting (HP:0000127) | 1.86088936 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85009778 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85009778 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85009778 |
| 74 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.84290870 |
| 75 | Myocardial infarction (HP:0001658) | 1.83123101 |
| 76 | Hyperkalemia (HP:0002153) | 1.82900859 |
| 77 | Abnormality of the intrinsic pathway (HP:0010989) | 1.82431386 |
| 78 | Acanthocytosis (HP:0001927) | 1.78248031 |
| 79 | Abnormality of vitamin metabolism (HP:0100508) | 1.76598278 |
| 80 | Abnormality of the periventricular white matter (HP:0002518) | 1.76124569 |
| 81 | Goiter (HP:0000853) | 1.71361360 |
| 82 | Osteomalacia (HP:0002749) | 1.70110055 |
| 83 | Eczematoid dermatitis (HP:0000976) | 1.69803479 |
| 84 | Neurofibrillary tangles (HP:0002185) | 1.67650510 |
| 85 | Hypoalphalipoproteinemia (HP:0003233) | 1.66501307 |
| 86 | Dysostosis multiplex (HP:0000943) | 1.65550141 |
| 87 | Orchitis (HP:0100796) | 1.64188209 |
| 88 | Infertility (HP:0000789) | 1.64159096 |
| 89 | Myositis (HP:0100614) | 1.63338929 |
| 90 | Hypertriglyceridemia (HP:0002155) | 1.63334315 |
| 91 | Polygenic inheritance (HP:0010982) | 1.62882865 |
| 92 | Hypokalemia (HP:0002900) | 1.62774884 |
| 93 | Recurrent bronchitis (HP:0002837) | 1.61869170 |
| 94 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.61264609 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 1.61011769 |
| 96 | Abnormality of chloride homeostasis (HP:0011422) | 1.60229734 |
| 97 | Ventricular fibrillation (HP:0001663) | 1.59932074 |
| 98 | Metabolic alkalosis (HP:0200114) | 1.59220711 |
| 99 | Increased circulating renin level (HP:0000848) | 1.59213027 |
| 100 | Epistaxis (HP:0000421) | 1.58867957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.61278980 |
| 2 | MAPK15 | 2.96803881 |
| 3 | RIPK1 | 2.69878627 |
| 4 | RIPK4 | 2.38980619 |
| 5 | TRIB3 | 2.32359638 |
| 6 | BLK | 2.14497232 |
| 7 | TYK2 | 2.03098113 |
| 8 | PRPF4B | 2.02796734 |
| 9 | NTRK3 | 1.96203567 |
| 10 | FGFR4 | 1.85897586 |
| 11 | MAPKAPK3 | 1.77870632 |
| 12 | FGFR3 | 1.74898858 |
| 13 | TNK2 | 1.63712449 |
| 14 | PRKAA2 | 1.61265931 |
| 15 | MAP3K2 | 1.54443704 |
| 16 | SGK2 | 1.52465763 |
| 17 | PDPK1 | 1.51637863 |
| 18 | EPHA3 | 1.47747363 |
| 19 | EEF2K | 1.42188936 |
| 20 | MAPK12 | 1.39124612 |
| 21 | JAK1 | 1.33346222 |
| 22 | MAP3K13 | 1.29946622 |
| 23 | PDK1 | 1.28223010 |
| 24 | SGK3 | 1.27666880 |
| 25 | SGK494 | 1.25502793 |
| 26 | SGK223 | 1.25502793 |
| 27 | JAK2 | 1.23599721 |
| 28 | FRK | 1.22546807 |
| 29 | MAP3K3 | 1.21414617 |
| 30 | PIK3CG | 1.20919905 |
| 31 | MARK2 | 1.18131645 |
| 32 | CSK | 1.16082718 |
| 33 | FES | 1.14999523 |
| 34 | RET | 1.12376734 |
| 35 | MAP3K7 | 1.06546128 |
| 36 | PIK3CA | 1.06023864 |
| 37 | KSR2 | 1.05410519 |
| 38 | MAP3K1 | 1.04146410 |
| 39 | CAMKK1 | 1.03583563 |
| 40 | DAPK2 | 1.03055833 |
| 41 | CAMKK2 | 1.01837140 |
| 42 | TBK1 | 0.99648913 |
| 43 | EPHB1 | 0.97974648 |
| 44 | TGFBR2 | 0.97679322 |
| 45 | TAOK3 | 0.94352229 |
| 46 | ZAP70 | 0.92715754 |
| 47 | NEK9 | 0.91382633 |
| 48 | MAP2K3 | 0.90091002 |
| 49 | SGK1 | 0.89745279 |
| 50 | MAPK7 | 0.88829516 |
| 51 | NEK6 | 0.88192721 |
| 52 | PINK1 | 0.87985340 |
| 53 | MAPK11 | 0.85906531 |
| 54 | MAP4K1 | 0.85439434 |
| 55 | FER | 0.83654519 |
| 56 | ACVR1B | 0.83455324 |
| 57 | NLK | 0.81692924 |
| 58 | ICK | 0.81255795 |
| 59 | ERBB2 | 0.81167725 |
| 60 | TRPM7 | 0.80794958 |
| 61 | CDC42BPA | 0.78523833 |
| 62 | PRKACG | 0.78402891 |
| 63 | CAMK1D | 0.75353929 |
| 64 | JAK3 | 0.73653158 |
| 65 | IRAK1 | 0.73552091 |
| 66 | MAP2K1 | 0.69769709 |
| 67 | SYK | 0.68928499 |
| 68 | CSF1R | 0.68853784 |
| 69 | SIK1 | 0.67620754 |
| 70 | GRK6 | 0.66130477 |
| 71 | MAPK4 | 0.63999768 |
| 72 | MAP2K4 | 0.61884872 |
| 73 | PRKCZ | 0.59063061 |
| 74 | PRKAA1 | 0.58033944 |
| 75 | AKT3 | 0.57867197 |
| 76 | PRKD1 | 0.56623475 |
| 77 | ITK | 0.56579141 |
| 78 | CDK6 | 0.55310919 |
| 79 | MAP2K2 | 0.54395744 |
| 80 | PHKG2 | 0.53739998 |
| 81 | PHKG1 | 0.53739998 |
| 82 | IGF1R | 0.53480923 |
| 83 | HIPK2 | 0.52249605 |
| 84 | PDK2 | 0.52075610 |
| 85 | LYN | 0.51462307 |
| 86 | BTK | 0.50689672 |
| 87 | YES1 | 0.49808855 |
| 88 | DYRK1B | 0.49783297 |
| 89 | HCK | 0.49195240 |
| 90 | KIT | 0.48878776 |
| 91 | CAMK1 | 0.48844565 |
| 92 | PRKG1 | 0.48225236 |
| 93 | OBSCN | 0.47945307 |
| 94 | FYN | 0.47392536 |
| 95 | GRK5 | 0.44866447 |
| 96 | IKBKE | 0.44759166 |
| 97 | OXSR1 | 0.43926169 |
| 98 | PRKCQ | 0.43583299 |
| 99 | PKN1 | 0.43496871 |
| 100 | BMPR2 | 0.43267098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.31755631 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.17495949 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.09990956 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92182809 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.89795791 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.84941402 |
| 7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.73389489 |
| 8 | Retinol metabolism_Homo sapiens_hsa00830 | 2.71108831 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.68015371 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.63291827 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.62069605 |
| 12 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.24256050 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.19482072 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.13277741 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.12191654 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06435884 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96367149 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94812833 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.92504669 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.89353708 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81286318 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79676587 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79565484 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.72799139 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.68673740 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64694229 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.61227176 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.59725491 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44429028 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34170064 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.31344397 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.28888433 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28399576 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26393275 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.21665197 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13245319 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06296928 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04978944 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01222595 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98259632 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98243490 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95791965 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91012891 |
| 44 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90005965 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 0.83486316 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75205860 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70085579 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69384979 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69153319 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65746296 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60103409 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59016786 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58993090 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.58097194 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57513865 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51858270 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51620812 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.47059126 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47039256 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.46489090 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44295750 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44253470 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.42533322 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42306478 |
| 65 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40649510 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39902623 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38758869 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32833126 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.29541354 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27072681 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25915806 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25285592 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.24908182 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.24466809 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24222392 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24057927 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23501670 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23183152 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.22943485 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22477787 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.21155673 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19222763 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.18620242 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18370450 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.17967877 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15521824 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.15409110 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15060032 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.13682307 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13220348 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.11163003 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10668276 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.09374586 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.09100135 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07655243 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.05753438 |
| 97 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.04982888 |
| 98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.04784046 |
| 99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.04723316 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.04696710 |

